Patent intelligence · WO
WO 2005105843
INHIBITEURS DE VIH PROTEASE
INHIBITEURS DE VIH PROTEASE
Patent details — WO 2005105843
- Jurisdiction
- WO
- Status
- expired
- Grant date
- Nov 10, 2005
- Expiration
- Nov 5, 2025
- Applicant
- ARPIDA AS [DK]
- CPC classes
- A61P/3118
Quick answer
WO 2005105843 (INHIBITEURS DE VIH PROTEASE) is held by ARPIDA AS [DK]. Status: expired. Granted Nov 10, 2005. Expires Nov 5, 2025 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- ARPIDA AS [DK]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61P/3118
More from ARPIDA AS [DK]
Related pharmaceutical patents in our USPTO index.
Frequently asked questions
What is US patent 2005105843?
WO 2005105843 (INHIBITEURS DE VIH PROTEASE) is held by ARPIDA AS [DK]. Status: expired. Granted Nov 10, 2005. Expires Nov 5, 2025 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns WO 2005105843?
ARPIDA AS [DK] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 4 pharmaceutical patents for this assignee.
When does WO 2005105843 expire?
Our index shows an expiration date of Nov 5, 2025 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.